Navigation Links
Novel strategies target health care-associated infections
Date:3/14/2011

AUDIO: Washington University's Victoria Fraser, MD, talks about innovative new strategies to reduce health-care-associated infections.

Click here for more information.

Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.

Their research is funded by a grant from the U.S. Centers for Disease Control and Prevention (CDC).

"Health-care-associated infections are a significant public-health issue, nationally and internationally," says infectious diseases specialist Victoria Fraser, MD, acting chief of the Department of Medicine and principal investigator of the new research. "Working closely with the CDC for many years, we have made dramatic improvements in reducing infections in health-care settings, but significant challenges remain as the population ages and many patients are admitted to hospitals with multiple health problems."

In the United States, about one in 20 hospitalized patients get an infection during the course of their medical treatment, according to the CDC.

Washington University is one of five academic medical centers nationwide awarded a total of $10 million by the CDC as part of the Prevention Epicenter Program to develop and test new approaches for reducing health-care-associated infections. Fraser and her colleagues will work closely with Barnes-Jewish Hospital, St. Louis Children's Hospital and other BJC HealthCare hospitals.

"Washington University and BJC have played a long and valuable role in the Prevention Epicenter Program," says John Jernigan, MD, MS, director of CDC office of HealthCare-Associated Infection Prevention Research and Evaluation. "Their program is renowned for its leadership in the field of health-care-associated prevention research, and we look forward to continuing our research partnership together."

The innovative strategies being explored at Washington University and BJC hospitals include:

  • Investigating whether live micro-organisms called probiotics can reduce the risk of pneumonia in patients on ventilators by restoring the natural balance of intestinal bacteria. Patients on ventilators often are given antibiotics and can't eat a normal diet, which alters the bacteria in their gastrointestinal tract and allows dangerous bacteria to bloom. Pneumonia can develop if the bacteria move into the lungs.

  • Evaluating whether the new antibiotic fidaxomicin can prevent infection with Clostridium difficile, a bacteria that can cause severe diarrhea. The investigational drug has shown promise in treating the infection, but the researchers want to determine whether it also works as a preventive in high-risk patients, such as the elderly or those receiving chemotherapy.

  • Investigating biomarkers to identify early signs of urinary tract infections in patients with urinary catheters. The researchers are developing tools to distinguish colonization from true infections and working to identify new ways to prevent urinary tract infections.

  • Developing new strategies to reduce bloodstream infections in patients with central lines being treated outside of intensive-care units (ICUs). Bloodstream infections have decreased dramatically in ICU patients with central lines, but interventions to reduce infection rates in non-ICU patients have not been studied.

The other academic medical centers awarded CDC Epicenter grants are Rush University Medical Center, Duke University, Harvard University and the University of Pennsylvania. Washington University has been part of the CDC's Prevention Epicenter grant program since its inception in 1997.

"Discoveries made by Washington University researchers at BJC hospitals have had a tremendous impact on decreasing health-care-associated infections both locally and nationally," says Clay Dunagan, MD, BJC vice president, Center for Clinical Excellence. "We now have an opportunity to take that knowledge one step further, to develop new ways to prevent and treat these infections in our ongoing efforts to improve the care of patients."


'/>"/>

Contact: Caroline Arbanas
arbanasc@wustl.edu
314-286-0109
Washington University School of Medicine
Source:Eurekalert

Related medicine news :

1. Novel clinical trial aims to reduce recurrence of aggressive breast cancer
2. A novel prognostic marker for biliary atresia
3. Genome sequencing used to assess a novel form of Clostridium botulinum
4. Novel mechanism for control of gene expression revealed
5. Novel methods for improved breast cancer survival
6. Novel immune system-based gene therapy induces strong responses in metastatic melanoma, sarcoma
7. Novel surgery removes rare tumor, rebuilds trachea
8. Researchers reveal function of novel molecule that underlies human deafness
9. Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center
10. UCI researchers find novel memory-enhancing mechanism in brain
11. Novel imaging technique may reduce lymphedema in breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic Trainers’ ... during the summer of 2016. The program was made possible by a Pennsylvania ... Department of Health and Human Services Administration. The broadcast, Use Your Head: ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio ... the first national #QuackGivesBack campaign which supported local breast cancer organizations during National ... Quack Gives Back initiative, and we’re very pleased with the participation ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the ... advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, ... Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up with ...
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce ... service for Texas, they are expanding their presence in Dallas. One of the most ... will bring new jobs to the Dallas and Forth Worth market. STAT takes pride ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Australia Glaucoma Surgery Devices Market ... report, "Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices market. The report provides value, ... and average prices (USD) within market segement - ... company shares and distribution shares data for each ...
(Date:12/8/2016)... 8, 2016 Global Interventional Radiology Market: ... global interventional radiology market analyzes the current and ... an elaborate executive summary, including a market snapshot ... sub-segments. The research is a combination of ... bulk of our research efforts along with information ...
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
Breaking Medicine Technology: